Ampersand Medical and MedSpecialists to Market Samba Telemedicine System

Agreement Delivers a More Effective Way for Physicians to Access

Clinical Information



Apr 10, 2001, 01:00 ET from Ampersand Medical Corporation

    CHICAGO and CHARLOTTESVILLE, Va., April 10 /PRNewswire/ -- A new system
 being introduced in North America will allow physicians a better and more
 efficient method of accessing clinical data, including medical images from
 services such as pathology, dermatology, hematology, microbiology, and
 radiology, via a secure internet connection.
     The system is the result of a joint agreement between Ampersand Medical
 Corporation (Nasdaq:   AMPM), owner of the Samba(TM) Telemedicine System, and
 MedSpecialists Inc., a leading provider of medical specialty
 information-management solutions.
     Under terms of the pact, MedSpecialists will market Samba Technologies
 image-management and communications applications as part of the company's
 medical specialty-specific clinical offerings.  Samba is a leading European
 medical-image management and communication system that includes text formats
 in computer-based patient documents.
     Marketed through MedSpecialists' direct sales force, the new tool provides
 physicians with a combination of ready access and unparalleled productivity
 and informational tools.  It also offers an affordable solution for medical
 facilities without advanced computerized resources.
     "Combining our specialty focused workflow solutions with Samba imaging
 capabilities will give physicians ready access to capturing and accessing
 comprehensive clinical information," said Michael Kappel, chief executive
 officer of MedSpecialists.  "Samba's ability to integrate medical images from
 the entire patient-care process and integrate it with all other relevant
 medical information makes it a smart combination for today's market."
     Samba Technologies is a wholly owned subsidiary of Ampersand Medical,
 based in Grenoble, France.  Samba Technologies is well known outside North
 America for its expertise in medical imaging solutions and expertise.  Its
 image-management and communications applications have been available in Europe
 since the mid-1990s, and more than 120 customers use the Samba Telemedicine
 applications in Europe.  MedSpecialists will be the first to offer these
 applications in North America.
     "In Europe, the Samba technology repeatedly has demonstrated its ability
 to integrate medical images from different areas of health care into a
 cohesive case and to manage the information accordingly," said Peter Gombrich,
 Ampersand chairman and chief executive officer.  "When Samba is combined with
 the MedSpecialists offering, it eliminates the need for large-scale hardware
 and the associated costly capital expenditures.  At the same time, it will
 give users access to software tools and clinical information that will enable
 them to work smarter and more efficiently."
     The addition of the Samba imaging applications to the MedSpecialists
 product line will enhance general diagnostic services, including pathology,
 dermatology, hematology, microbiology, and radiology services.  It will also
 provide access to high quality images for the treating physician, addressing
 important workflow and outreach challenges.
 
     About MedSpecialists
     Based in Charlottesville, VA, MedSpecialists is a healthcare software and
 services company dedicated to improving efficiency in the delivery of
 specialty medicine.  MedSpecialists assists healthcare providers by acquiring,
 aggregating and organizing all manner of clinical data and making it
 accessible via a secure Internet service.  It permits the centralization of
 scarce and sophisticated medical technologies and facilitates professional
 collaboration among conferring specialists.  These services have the potential
 of significantly reducing total capital expenditures and provide medical
 device manufacturers and specialty application developers with a more cost
 effective method of introducing new technology to the specialty marketplace.
 The company's Web site is www.medspecialists.net .
 
     About Ampersand Medical
     Ampersand Medical Corporation develops cost-effective, laboratory-based
 and point-of-care screening systems to assist in the early detection of
 cervical and other cancers.  The InPath(TM) System is being developed to
 provide medical practitioners with a highly accurate, low-cost, cervical
 cancer screening system that can be used at the point-of-care.  Other products
 include AIM 2000, an automated system facilitating the analysis of medical
 samples and SAMBA(TM) Virtual Laboratory software used for medical image
 processing, database and multimedia case management, telepathology and
 teleradiology.
 
     Certain statements throughout this release are forward-looking.  These
 statements are based on the Company's current expectations and involve many
 risks and uncertainties, such as the possibility that clinical trials will not
 substantiate the Company's expectations with respect to the InPath(TM) System,
 and other factors set forth in reports and documents filed by Ampersand
 Medical Corporation with the Securities and Exchange Commission.  Ampersand
 Medical Corporation undertakes no obligation to publicly update or revise any
 forward-looking statements contained herein.
 
     More information is available on the Internet at
 www.ampersandmedical.com .
 
     CONTACT:  Media, Gail Cowan, 312-832-9300, ext. 212, or Investors, Kristin
 Anderson, 312-832-9300 ext. 256, both of Corporate Technology Communications
 for Ampersand Medical
 
 

SOURCE Ampersand Medical Corporation
    CHICAGO and CHARLOTTESVILLE, Va., April 10 /PRNewswire/ -- A new system
 being introduced in North America will allow physicians a better and more
 efficient method of accessing clinical data, including medical images from
 services such as pathology, dermatology, hematology, microbiology, and
 radiology, via a secure internet connection.
     The system is the result of a joint agreement between Ampersand Medical
 Corporation (Nasdaq:   AMPM), owner of the Samba(TM) Telemedicine System, and
 MedSpecialists Inc., a leading provider of medical specialty
 information-management solutions.
     Under terms of the pact, MedSpecialists will market Samba Technologies
 image-management and communications applications as part of the company's
 medical specialty-specific clinical offerings.  Samba is a leading European
 medical-image management and communication system that includes text formats
 in computer-based patient documents.
     Marketed through MedSpecialists' direct sales force, the new tool provides
 physicians with a combination of ready access and unparalleled productivity
 and informational tools.  It also offers an affordable solution for medical
 facilities without advanced computerized resources.
     "Combining our specialty focused workflow solutions with Samba imaging
 capabilities will give physicians ready access to capturing and accessing
 comprehensive clinical information," said Michael Kappel, chief executive
 officer of MedSpecialists.  "Samba's ability to integrate medical images from
 the entire patient-care process and integrate it with all other relevant
 medical information makes it a smart combination for today's market."
     Samba Technologies is a wholly owned subsidiary of Ampersand Medical,
 based in Grenoble, France.  Samba Technologies is well known outside North
 America for its expertise in medical imaging solutions and expertise.  Its
 image-management and communications applications have been available in Europe
 since the mid-1990s, and more than 120 customers use the Samba Telemedicine
 applications in Europe.  MedSpecialists will be the first to offer these
 applications in North America.
     "In Europe, the Samba technology repeatedly has demonstrated its ability
 to integrate medical images from different areas of health care into a
 cohesive case and to manage the information accordingly," said Peter Gombrich,
 Ampersand chairman and chief executive officer.  "When Samba is combined with
 the MedSpecialists offering, it eliminates the need for large-scale hardware
 and the associated costly capital expenditures.  At the same time, it will
 give users access to software tools and clinical information that will enable
 them to work smarter and more efficiently."
     The addition of the Samba imaging applications to the MedSpecialists
 product line will enhance general diagnostic services, including pathology,
 dermatology, hematology, microbiology, and radiology services.  It will also
 provide access to high quality images for the treating physician, addressing
 important workflow and outreach challenges.
 
     About MedSpecialists
     Based in Charlottesville, VA, MedSpecialists is a healthcare software and
 services company dedicated to improving efficiency in the delivery of
 specialty medicine.  MedSpecialists assists healthcare providers by acquiring,
 aggregating and organizing all manner of clinical data and making it
 accessible via a secure Internet service.  It permits the centralization of
 scarce and sophisticated medical technologies and facilitates professional
 collaboration among conferring specialists.  These services have the potential
 of significantly reducing total capital expenditures and provide medical
 device manufacturers and specialty application developers with a more cost
 effective method of introducing new technology to the specialty marketplace.
 The company's Web site is www.medspecialists.net .
 
     About Ampersand Medical
     Ampersand Medical Corporation develops cost-effective, laboratory-based
 and point-of-care screening systems to assist in the early detection of
 cervical and other cancers.  The InPath(TM) System is being developed to
 provide medical practitioners with a highly accurate, low-cost, cervical
 cancer screening system that can be used at the point-of-care.  Other products
 include AIM 2000, an automated system facilitating the analysis of medical
 samples and SAMBA(TM) Virtual Laboratory software used for medical image
 processing, database and multimedia case management, telepathology and
 teleradiology.
 
     Certain statements throughout this release are forward-looking.  These
 statements are based on the Company's current expectations and involve many
 risks and uncertainties, such as the possibility that clinical trials will not
 substantiate the Company's expectations with respect to the InPath(TM) System,
 and other factors set forth in reports and documents filed by Ampersand
 Medical Corporation with the Securities and Exchange Commission.  Ampersand
 Medical Corporation undertakes no obligation to publicly update or revise any
 forward-looking statements contained herein.
 
     More information is available on the Internet at
 www.ampersandmedical.com .
 
     CONTACT:  Media, Gail Cowan, 312-832-9300, ext. 212, or Investors, Kristin
 Anderson, 312-832-9300 ext. 256, both of Corporate Technology Communications
 for Ampersand Medical
 
 SOURCE  Ampersand Medical Corporation